Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

First-pass elimination. Basic concepts and clinical consequences.

S M Pond, T N Tozer

    Clinical Pharmacokinetics
    |January 1, 1984
    PubMed
    Summary
    This summary is machine-generated.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Correction for Volume Shift during Equilibrium Dialysis by Measurement of Protein Concentration.

    Pharmaceutical research·2013
    Same author

    Pharmacokinetics and metabolic fate of two nitroxides potentially useful as contrast agents for magnetic resonance imaging.

    Pharmaceutical research·2013
    Same author

    Pharmacokinetics of two prototype nitroxide spin labels for contrast enhancement in magnetic resonance imaging.

    Pharmaceutical research·2013
    Same author

    Mitochondrial ultrastructure and density in a primate model of persistent tardive dyskinesia.

    Life sciences·2001
    Same author

    The serotonin transporter gene and Parkinson's disease.

    European neurology·2000
    Same author

    Further characterisation of the interaction of haloperidol metabolites with neurotransmitter transporters in rat neuronal cultures and in transfected COS-7 cells.

    Naunyn-Schmiedeberg's archives of pharmacology·2000
    Same journal

    Population Pharmacokinetic Modelling of Dolutegravir: A Narrative Review.

    Clinical pharmacokinetics·2026
    Same journal

    Partial Area Under the Curve: A Revelatory Story in Pharmacokinetics.

    Clinical pharmacokinetics·2026
    Same journal

    Informing Sampling Design for Lung Distribution Studies Using a Pulmonary Population Minimal PBPK Model.

    Clinical pharmacokinetics·2026
    Same journal

    Revisited Pharmacokinetic Profiles of Methylprednisolone in Plasma and Urine After Single and Multiple Oral Administrations: Relevance in Sports Drug Testing.

    Clinical pharmacokinetics·2026
    Same journal

    ALBI Grade is a Determinant of Lenvatinib Pharmacokinetics, Efficacy, and Toxicities in Japanese Patients with Hepatocellular Carcinoma.

    Clinical pharmacokinetics·2026
    Same journal

    Quantitative Pharmacology Justifying Ribociclib Dose in Early Breast Cancer.

    Clinical pharmacokinetics·2026
    See all related articles

    First-pass metabolism significantly impacts drug bioavailability, especially for oral medications. Understanding this process is crucial for determining effective drug dosages and routes of administration.

    Area of Science:

    • Pharmacokinetics
    • Drug Metabolism
    • Bioavailability Studies

    Background:

    • First-pass metabolism is the drug degradation that occurs between administration and systemic circulation.
    • The liver and gastrointestinal tract are primary sites, influencing drug efficacy and dosage.
    • Variable first-pass metabolism necessitates careful consideration in drug development and clinical use.

    Purpose of the Study:

    • To elucidate the mechanisms and implications of first-pass metabolism in drug disposition.
    • To review physiological factors affecting first-pass metabolism and bioavailability.
    • To compare pharmacokinetic models for predicting drug behavior.

    Main Methods:

    • Review of pharmacokinetic principles and drug metabolism pathways.

    Related Experiment Videos

  • Analysis of bioavailability as a measure of first-pass effect.
  • Comparison of 'well-stirred' and 'parallel tube' models for predicting drug behavior.

    • Main Results:

    • First-pass metabolism significantly reduces oral drug bioavailability.
    • Physiological factors like enzyme activity and blood flow critically influence metabolism.
    • Model predictions diverge significantly, especially for drugs with low bioavailability.

    Conclusions:

    • Extensive first-pass metabolism requires higher oral doses than intravenous doses for equivalent effects.
    • Some drugs are unsuitable for oral administration due to high first-pass metabolism.
    • Accurate modeling is essential for predicting drug behavior and optimizing therapeutic outcomes.